ACAN and arthritic joint disease: ADAMTS5 has become a major drug target for arthritis therapy as ADAMTS5 knockout mice (Adamts5-/- mice) are resistant to aggrecan cleavage in articular cartilage and are thus protected from experimentally induced arthritis [14,15].